Navamedic ASA (OSL: NAVA)
29.10
0.00 (0.00%)
Aug 30, 2024, 4:25 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 156.31M NOK in the quarter ending June 30, 2024, with 26.09% growth. This brings the company's revenue in the last twelve months to 543.49M, up 19.59% year-over-year. In the year 2023, Navamedic ASA had annual revenue of 512.00M with 33.98% growth.
Revenue (ttm)
543.49M
Revenue Growth
+19.59%
P/S Ratio
0.93
Revenue / Employee
12.08M
Employees
45
Market Cap
507.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
Dec 31, 2019 | 188.76M | 4.84M | 2.63% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |